These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17112774)

  • 1. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
    Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
    Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
    Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
    Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
    J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).
    Stoehlmacher-Williams J; Obermann L; Ehninger G; Goekkurt E
    Anticancer Res; 2012 Feb; 32(2):421-5. PubMed ID: 22287728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
    Press OA; Zhang W; Gordon MA; Yang D; Lurje G; Iqbal S; El-Khoueiry A; Lenz HJ
    Cancer Res; 2008 Apr; 68(8):3037-42. PubMed ID: 18413774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor gene polymorphisms, R497K, but not (CA)n repeat, is associated with dilated cardiomyopathy.
    Zhou B; Rao L; Peng Y; Zhang Q; Zhang L
    Clin Chim Acta; 2009 May; 403(1-2):184-7. PubMed ID: 19265688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Wang HS; Su Y
    Clin Cancer Res; 2007 Jun; 13(12):3597-604. PubMed ID: 17575224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
    Wang L; Rodriguez M; Kim ES; Xu Y; Bekele N; El-Naggar AK; Hong WK; Mao L; Oh YW
    Int J Oncol; 2004 Oct; 25(4):993-9. PubMed ID: 15375549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
    Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
    Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer.
    Lundberg M; Pajusto M; Koskinen WJ; Mäkitie AA; Aaltonen LM; Mattila PS
    Head Neck; 2009 May; 31(5):664-72. PubMed ID: 19260117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and mutation analysis of her2 in head and neck squamous cell carcinoma.
    Ali MA; Gunduz M; Gunduz E; Tamamura R; Beder LB; Katase N; Hatipoglu OF; Fukushima K; Yamanaka N; Shimizu K; Nagatsuka H
    Cancer Invest; 2010 Jun; 28(5):495-500. PubMed ID: 20014947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
    J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
    Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
    Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil.
    Na II; Kang HJ; Cho SY; Koh JS; Lee JK; Lee BC; Lee GH; Lee YS; Yoo HJ; Ryoo BY; Yang SH; Shim YS
    Eur J Cancer; 2007 Feb; 43(3):520-6. PubMed ID: 17224267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.
    Spindler KL; Nielsen JN; Lindebjerg J; Brandslund I; Jakobsen A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):500-4. PubMed ID: 16757132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.